Cynthiana, Kentucky
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase
2Span
153 weeksSponsor
Gilead SciencesCamarillo, California
Recruiting
Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain
Phase
N/ASpan
156 weeksSponsor
Saluda Medical Pty LtdCamarillo, California
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
In this study the treatment group will include all patients receiving MILD, and the control group will include all patients receiving IPD for the treatment of LSS during the enrollment period. Reoperation and harms data will be studied for the MILD and IPD procedures for a 24-month follow-up period after the index procedure using Medicare claims data. This study is exempt from IRB oversight (Department of Health and Human Services regulations 45 CFR 46) and does not require prior enrollment nor patient consent. The inclusion of the study's NCT number on MILD Medicare claims is required and results in enrollment.
Phase
N/ASpan
512 weeksSponsor
Vertos Medical, Inc.Camarillo, California
Recruiting
1-3 of 3